Arkolith/Insider Trading/HALO/Form 4

Caudill Cortney

SVP, CHIEF OPERATING OFFICERHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Mar 10, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2026Sell(S)9K$67.64$599K7K
Mar 10, 2026Option exercise(M)2K$33.51$52K16K
Mar 9, 2026Sell(S)2K$68.25$143K14K
Mar 9, 2026Sell(S)18K$67.75$1.2M16K
Mar 9, 2026Option exercise(M)20K$33.51$670K34K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 10, 2026Option exercise(M)2K$33.51$52K68K
Mar 9, 2026Option exercise(M)20K$33.51$670K69K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML